00000nam 2200000zi 4500 9.924899 CaOODSP 20240311151556 m o d f cr ||||||||||| 230710t20232023onc o f00| 0 eng d 9780660494289 CaOODSP eng rda CaOODSP n-cn--- H14-443/2023E-PDF Mpox immunization coverage survey among 2SLGBTQI+ and men who have sex with men : methodological report. [Ottawa] : Public Health Agency of Canada = Agence de la santé publique du Canada, 2023. ©2023 1 online resource (33 pages) + executive summary (5 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Enquête sur la couverture vaccinale contre la variole simienne chez les 2SLGBTQI+ et les hommes ayant des rapports sexuels avec des hommes : rapport méthodologique. "Supplier name: Advanis Inc." "Contract number: 6D142-226171." "Registration number: POR 139-22." "The purpose of this survey was to provide information on mpox vaccine coverage for the 2SLGBTQI+ as well as MSM adult populations, and to help understand the knowledge, attitudes, and beliefs concerning mpox vaccines (e.g., vaccine effectiveness, vaccine safety, vaccine relevance). This includes exploring reasons for vaccine hesitancy and vaccine refusal and the impact this has on vaccine uptake as well as obstacles for non-vaccination of mpox. Its purpose was also to identify risk factors for transmission of mpox as well as these populations’ willingness to limit high-risk activities amid the current mpox outbreak"--page 4. Human monkeypox Vaccination Canada Public opinion. Public opinion Canada. Sexual minorities Canada Attitudes. Public Health Agency of Canada, issuing body. Advanis (Firm), consultant. Enquête sur la couverture vaccinale contre la variole simienne chez les 2SLGBTQI+ et les hommes ayant des rapports sexuels avec des hommes : (CaOODSP)9.924902 Mpox immunization coverage survey among 2SLGBTQI+ and men who have sex with men, 2024 : (CaOODSP)9.935235 PDF 994 KB https://publications.gc.ca/collections/collection_2023/aspc-phac/H14-443-2023-eng.pdf Methodological Report PDF 373 KB https://publications.gc.ca/collections/collection_2023/aspc-phac/H14-443-2023-1-eng.pdf Executive Summary HTML N/A https://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/139-22-e/139-22_report.html Methodological Report HTML N/A https://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/139-22-e/summary/139-22_summary.html Executive Summary